Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
Shhh! 3 Secret Pharma Stocks Flying Below Wall Street's Radar
06:15am, Friday, 03'rd May 2024
Pharma stocks and massive potential go hand in hand. With devastating diseases like cancer, diabetes and heart disease still far from finding a cure, drugs that treat these conditions often command ex
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know
06:51pm, Thursday, 02'nd May 2024
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $400.16, representing a -0.49% change from its previous close.
Unveiling Vertex (VRTX) Q1 Outlook: Wall Street Estimates for Key Metrics
10:21am, Wednesday, 01'st May 2024
Besides Wall Street's top -and-bottom-line estimates for Vertex (VRTX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qua
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
10:06am, Wednesday, 01'st May 2024
Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
11:06am, Monday, 29'th Apr 2024
Vertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2 Top Growth Stocks to Buy Right Now and Hold Forever
08:45am, Sunday, 28'th Apr 2024
The healthcare industry tends to do well in all types of economies. Vertex just garnered a new blockbuster approval, and more could be around the corner.
Want $1 Million in Retirement? 3 Stocks to Buy Now And Hold for Decades.
05:50am, Saturday, 27'th Apr 2024
Amazon has multiple business moats and ways to continue growing. MercadoLibre is well positioned to capitalize on the massive opportunities in Latin America.
2 Fantastic Growth Stocks to Buy Right Now
09:45am, Thursday, 25'th Apr 2024
Healthcare and digital advertising are mammoth industries. Vertex is widening its moat across the rare disease drug market.
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
09:10am, Tuesday, 23'rd Apr 2024
Vertex (VRTX) signs a collaboration agreement with TreeFrog to utilize the latter's C-Stem technology in order to optimize the production of its T1D cell therapies.
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
06:05am, Tuesday, 23'rd Apr 2024
Vertex has built a billion-dollar business thanks to its expertise in treating cystic fibrosis. The biotech stock is cheaper today than it was earlier this year in relation to expected earnings.
If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today
07:16am, Monday, 22'nd Apr 2024
Vertex is a leader in cystic fibrosis treatment but also is showing it can succeed in other disease areas. The company recently won approval for a gene-editing treatment for blood disorders.
Looking for Once-in-a-Generation Investment Opportunities? Here Are 3 Magnificent Stocks to Buy Right Now
05:52am, Monday, 22'nd Apr 2024
One of these magnificent stocks could be a big winner in a new $4 trillion market. Another is a leader in using AI to automate online processes.
2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever
09:45am, Saturday, 20'th Apr 2024
Great pharma companies tend to be entrenched in lucrative markets. Vertex Pharmaceuticals is managing to diversify off a strong base.
3 Relatively Safe Growth Stocks You Can Buy and Hold
06:48am, Saturday, 20'th Apr 2024
Eli Lilly has crushed the S&P 500 over the last 12 months and could continue delivering outsized returns. Novo Nordisk's strong fundamentals and solid growth opportunities make it a no-brainer buy.
3 Biotech Stocks Set to Double by 2028
06:15am, Saturday, 20'th Apr 2024
Biotech stocks offer the possibility of groundbreaking medical advancements alongside the potential for explosive growth. While the sector carries inherent risks, a select group of biotech companies p
